SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap's stock is surging as investors react to a Q3 earnings beat, a $500 million stock buyback, and a new $400 million AI partnership with Perplexity. The community is buzzing about the potential for a short squeeze and upgraded price targets, while also weighing concerns about profitability and the long-term sustainability of the rally.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is trending as investors anticipate upcoming earnings results, with many in the community expecting strong numbers driven by growth and the Alani Nu acquisition. Despite overall market uncertainty, the community expresses long-term confidence in CELH's execution and potential, while also closely monitoring potential short-term volatility and market manipulation.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors anticipate Phase 3 data for their DMD treatment, deramiocel, expected mid-Q4, with the community actively discussing potential FDA approval pathways. Discussions also involve the StealthX exosome platform and recent job postings at Capricor and NS Pharma, hinting at possible positive outcomes. Community members are closely monitoring short interest and options activity, speculating on potential market reactions following the data release.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is trending as traders assess the semiconductor sector's near-term trajectory amidst AI optimism and US-China trade concerns. Community discussions include reactions to earnings reports from key semiconductor companies and speculation about upcoming economic data releases and Federal Reserve actions. Bullish sentiment persists, while some are wary of overvaluation and the potential for a pullback.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending amid speculation about potential partnerships or a buyout, with an earlier earnings call fueling anticipation. Community members are debating the likelihood of a deal, with some eyeing AstraZeneca as a possible partner, while others express skepticism and frustration with management. Bullish sentiment is building as some traders position for a potential breakout and short squeeze ahead of earnings.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amid speculation about a potential acquisition, with the community closely watching for a deal announcement, especially with earnings on the horizon.  Executive share selling and potential offers are hot topics.  The stock's valuation and possible bidding war dynamics are also being heavily debated by investors.

Caledonia Mining Corp. Plc engages in the exploration, development, and production of gold and other precious metals from its mineral properties. Its projects include Blanket Gold Mine and Maligreen. The company was founded on February 5, 1992 and is headquartered in St. Helier, the United Kingdom.

Caledonia Mining Corporation Plc

Caledonia Mining Corporation ($CMCL) is trending due to upcoming earnings and discussions around its potential growth, particularly the Bilboes project which could significantly increase production; the earnings are scheduled to be released Monday before the market opens. Community members are weighing the company's profitability against the political risks of operating in Zimbabwe, with some anticipating a positive impact from rising gold prices and others concerned about potential dilution from financing activities. Recent discussions also touch on the stock's valuation relative to its growth potential and comparison to other gold miners.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT) is trending as community members discuss its tokenomics, specifically the locked dev tokens until February and scheduled buybacks, which some believe will naturally increase the coin price.  Concerns about competitors potentially suppressing the token's price and calls for fair play are also circulating.  Traders are actively watching key price levels and anticipating potential volatility, with some suggesting it's time for a rebound.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

DVAX is trending due to a new $100 million share buyback program and updates regarding a partnership with VXRT for a novel oral COVID-19 vaccine. The community is discussing the potential financial benefits and strategic implications of this agreement, as well as concerns about delays in the FDA study protocol for HLAD in adults on hemodialysis. Investors are also weighing in on the impact of Deep Track's involvement and management's capital allocation decisions.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as the community discusses its potential for future growth and staking opportunities. Many users are accumulating and staking $SWEAT, motivated by the project's concept of earning crypto through walking and its potential for long-term gains. The conversation also highlights anticipation for increased utility and adoption of the Sweat Wallet in the US.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Geopolitical Windfall for Indian ETFs as Trump Hints at Tariff Cut 

Indian ETFs like INDA and FLIN gain spotlight as U.S.-India trade deal seems to near, which could slash tariffs and reignite investor confidence. 

Decent Growth Vs. Tariff Fears: What Lies Ahead of India ETFs?

India's economy grew at an annual rate of 7.8% in the quarter ending June, topping economists' expectations of 6.7% (Reuters poll), as quoted on CNBC.

Shares of MakeMyTrip ($MMYT) jumped 6% on Thursday as the online travel company reported strong revenue jump for its third-quarter earnings compared to last year but missed earnings estimates, with retail sentiment staying bearish.MakeMyTrip posted diluted earnings per share of $0.23, below the consensus estimate that Wall Street analysts expected at $0.27, according to Stocktwits data.&nbsp;However, Its revenues stood at $267.4 million, jumping 24.8% year-over-year, beating consensus estimates of $268.1 million.The increase in revenue was primarily due to strong travel demand in India for both domestic and international outbound travel in the quarter, the company said. The revenue increase was led by its hotels and packages business which saw an increase of 23.4% over the last quarter to $121.9 million.As at December 31, the company's cash and cash equivalents and term deposits stood at $705.5 million.“The Indian travel and tourism sector is witnessing robust growth, reflecting a strong desire among travelers to explore new horizons. While Indian destinations continue to shine, many countries have made significant efforts to attract Indian travelers. Our strong performance this quarter reflects these macro trends, along with our focused execution and commitment to customer centricity," Rajesh Magow, Group CEO said.Sentiment on Stocktwits inched up to 'bearish' from 'extremely bearish.' Message volumes were in the 'high' zone compared to 'extremely high' a day ago.<figure class="image"><img style="aspect-ratio:1292/308;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_24_at_8_49_50_AM_778ce36030.png" alt="Screenshot 2025-01-24 at 8.49.50 AM.png" width="1292" height="308"><figcaption>MakeMyTrip sentiment meter and message volumes on Jan 23 as of 10:40 pm ET</figcaption></figure>To be sure, some commenters on the Stocktwits platform were still bullish.<stembedurl>https://stocktwits.com/NotaTraitor/message/601144059</stembedurl>MakeMyTrip offers air ticketing, hotels and packages, and rail tickets, among other ancillary travel services. &nbsp;MakeMyTrip stock is down 2.53% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com

Representative image. Source: Getty Images

MakeMyTrip Stock Surges After Q3 Revenue Jump: Retail's Not Convinced

Its revenues stood at $267.4 million, jumping 24.8% year-over-year, beating consensus estimates

Equity

Shares of MakeMyTrip ($MMYT) have fallen about 2% in the past five days ahead of the online travel company’s third-quarter earnings, dampening retail sentiment.MakeMyTrip will report its financial and operating results before the bell on Thursday, January 23.Wall Street analysts expect $0.27 in earnings per share on estimated revenues of $264.99 million, according to Stocktwits data. The full year 2025's EPS is expected to be about $1.04 per share on revenue of $989.86 million.For the second quarter, MakeMyTrip reported $210.99 million in revenues, missing analyst expectations. Its EPS stood at $0.16, also falling short of estimates of $0.18.Sentiment on Stocktwits was in the ‘extremely bearish’ zone compared to last week. Message volumes have increased to ‘extremely high’ from ‘high.’ <img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_23_at_7_03_01_AM_e22d3a31b6.png" alt="Screenshot 2025-01-23 at 7.03.01 AM.png"> However, BofA analyst Sachin Salgaonkar took a more positive view on the stock, raising the firm's price target to $130 from $119 with a ‘Buy’ rating, Fly.com reported.According to the analyst, normal strong seasonality trends have been in play in the third quarter for the industry and MakeMyTrip is expected to report "a strong set of numbers in the seasonally strong" quarter, added the report.MakeMyTrip offers air ticketing, hotels and packages, and rail tickets, among other ancillary travel services. &nbsp;MakeMyTrip stock is down 8% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com

MakeMyTrip Stock In Focus Ahead of Q3 Earnings: Retail’s Downbeat

Sentiment on Stocktwits was in the ‘extremely bearish’ zone compared to last week.

Shares of MakeMyTrip ($MMYT) were in the spotlight on Friday morning after the company received a price target revision from Bofa Securities on the back of growing travel demand. However, retail sentiment remained ‘neutral.’Bofa analyst Sachin Salgaonkar raised the price target for MakeMyTrip from $119.00 to $130.00 with a ‘Buy’ rating, The Fly.com reported. The analyst reportedly has a positive outlook on the company's earnings potential and market position in the travel industry. Specifically, the roll forward of the company's discounted cash flow (DCF) analysis prompted the hike, Investing.com <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.investing.com/news/analyst-ratings/bofa-maintains-buy-on-makemytrip-stock-despite-minor-eps-impact-from-inr-weakness-93CH-3789828">reported.</a>The company’s recent $150 million share buyback program also serves as a safety net for the stock price and offers support to the company’s market valuation.MakeMyTrip stock has risen 2.32% in the past five days and is up 153% year-to-date.Retail sentiment on Stocktwits was ‘neutral’ with message volumes leaning high, showing increased investor attention on the stock.<figure class="image"><img style="aspect-ratio:1256/302;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_27_at_7_27_37_PM_8c1788e1d5.png" alt="Screenshot 2024-12-27 at 7.27.37 PM.png" width="1256" height="302"><figcaption>MMYT sentiment meter and message volumes on Dec 27th as of 9:15 am ET</figcaption></figure>Several commenters on Stocktwits, however, were bullish on the overall prospects for travel stocks.<stembedurl>https://stocktwits.com/MaverikIT/message/597866494</stembedurl><stembedurl>https://stocktwits.com/MaverikIT/message/597653965</stembedurl><stembedurl>https://stocktwits.com/AskLou/message/597468745</stembedurl>MakeMyTrip offers air ticketing, hotels and packages, and rail tickets, among other ancillary travel services. &nbsp;The company is expected to report third-quarter earnings in January. Wall Street analysts expect $0.27 in earnings per share on estimated revenues of $264.99 million.For updates and corrections, email newsroom[at]stocktwits[dot]com.

MakeMyTrip Stock In Spotlight After BofA’s Price Target Revision: But Retail's Neutral

MakeMyTrip stock has risen 2.32% in the past five days.

INQQ
Exchange Traded Concepts Trust - India Internet & Ecommerce ETF

Feed

News

Sentiment

Fundamentals

Info

Latest INQQ News

INQQExchange Traded Concepts Trust - India Internet & Ecommerce ETF